Allarity Therapeutics, Inc. SEC filings ALLR
Allarity Therapeutics, Inc. has 403 filings in SEC EDGAR's recent list, going back to May 27, 2021. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Other events
|
Nov 2, 2026 | Oct 28, 2026 |
| 424B5 | Prospectus supplement | Oct 30, 2026 | — |
| 8-K |
Current report
Agreement ended
|
Oct 30, 2026 | Oct 28, 2026 |
| 4 | Insider transaction | Oct 9, 2026 | Jan 22, 2026 |
| 8-K |
Current report
Other events
|
Oct 1, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Other events
|
Sep 29, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Other events
|
Sep 16, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Other events
|
Sep 14, 2026 | Sep 11, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jul 1, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Other events
|
Jun 22, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 2, 2026 | May 27, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | May 14, 2026 | Jan 28, 2026 |
| 4 | Insider transaction | May 11, 2026 | Jan 28, 2026 |
| 3 | Initial insider ownership | May 11, 2026 | Jun 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 8, 2026 | May 8, 2026 |
| 4 | Insider transaction | May 7, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Other events
|
May 6, 2026 | May 5, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 26, 2026 |
| 4/A | Ownership document | Apr 30, 2026 | Jan 28, 2026 |
| 4 | Insider transaction | Apr 30, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Other events
|
Apr 28, 2026 | Apr 27, 2026 |
| 424B3 | Prospectus | Apr 27, 2026 | — |
| EFFECT | Filing | Apr 24, 2026 | — |
| S-3/A | Amendment no. 1 to form s-3 | Apr 24, 2026 | — |
| CORRESP | Letter to the SEC | Apr 22, 2026 | — |
| 8-K |
Current report
Other events
|
Apr 22, 2026 | Apr 21, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2026 | Apr 10, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Mar 9, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 6, 2026 | Mar 2, 2026 |
| UPLOAD | Letter from the SEC | Feb 19, 2026 | — |
| 8-K |
Current report
Other events
|
Feb 19, 2026 | Feb 18, 2026 |
| S-3 | Shelf registration | Feb 12, 2026 | — |
| 8-K |
Current report
Other events
|
Feb 4, 2026 | Feb 3, 2026 |
| 424B5 | Prospectus supplement | Jan 29, 2026 | — |
| 8-K |
Current report
Material agreement
|
Jan 29, 2026 | Jan 28, 2026 |
| 4 | Insider transaction | Jan 16, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Dec 23, 2025 | Dec 23, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 8, 2025 | Dec 3, 2025 |
| EFFECT | Filing | Dec 5, 2025 | — |
| CORRESP | Letter to the SEC | Dec 4, 2025 | — |
| S-3 | Shelf registration | Dec 3, 2025 | — |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| EFFECT | Filing | Sep 30, 2025 | — |
| 424B3 | Prospectus | Sep 30, 2025 | — |
| CORRESP | Letter to the SEC | Sep 30, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2025 | — |
| S-3 | Shelf registration | Sep 25, 2025 | — |
| 8-K |
Current report
Other events
|
Sep 24, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 22, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Other events
|
Sep 22, 2025 | Sep 17, 2025 |
| 8-K |
Current report
Other events
|
Aug 27, 2025 | Aug 26, 2025 |
| 10-Q | Quarterly report | Aug 15, 2025 | Jun 30, 2025 |
| NT 10-Q | Notification of late filing | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
Jul 16, 2025 | Jul 15, 2025 |
| 3 | Initial insider ownership | Jul 14, 2025 | Jul 1, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
Jul 1, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
Jun 30, 2025 | Jun 27, 2025 |
| RW | Withdrawal of registration statement on form s-3 | Jun 24, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 20, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2025 | Jun 13, 2025 |
| DRS | Filing | Jun 16, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jun 11, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Other events
|
Jun 5, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Other events
|
Jun 3, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Other events
|
May 13, 2025 | May 12, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 9, 2025 | May 9, 2025 |
| ARS | Annual report to shareholders | May 1, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 13, 2025 |
| 8-K |
Current report
Other events
|
Apr 28, 2025 | Apr 25, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 16, 2025 | Apr 16, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
Mar 25, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Other events
|
Mar 18, 2025 | Mar 17, 2025 |
| 8-K |
Current report
Other events
|
Mar 14, 2025 | Mar 13, 2025 |
| 8-K |
Current report
Other events
|
Mar 7, 2025 | Mar 6, 2025 |
| 8-K |
Current report
Other events
|
Mar 4, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Other events
|
Feb 27, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Other events
|
Feb 25, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Other events
|
Feb 7, 2025 | Feb 6, 2025 |
| 8-K |
Current report
Other events
|
Jan 30, 2025 | Jan 30, 2025 |
| 4/A | Form 4/a | Jan 24, 2025 | Jan 22, 2025 |
| 4/A | Form 4/a | Jan 24, 2025 | Jan 22, 2025 |
| 4/A | Form 4/a | Jan 24, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| 8-K |
Current report
Other events
|
Nov 19, 2024 | Nov 18, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| 8-K |
Current report
Other events
|
Oct 23, 2024 | Oct 22, 2024 |
| 8-K |
Current report
Other events
|
Oct 11, 2024 | Oct 9, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 4, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 1, 2024 | Sep 30, 2024 |
| 3 | Initial insider ownership | Oct 1, 2024 | Sep 30, 2024 |
| 3 | Initial insider ownership | Sep 18, 2024 | Sep 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 17, 2024 | Sep 16, 2024 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Sep 13, 2024 | Sep 9, 2024 |
| 8-K/A |
Amended current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Sep 10, 2024 | Sep 3, 2024 |
| 424B5 | Prospectus supplement | Sep 9, 2024 | — |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Sep 9, 2024 | Sep 3, 2024 |
| S-3 | Shelf registration | Aug 30, 2024 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 29, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Aug 29, 2024 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Aug 21, 2024 | Aug 19, 2024 |
| DEFR14A | Proxy statement | Aug 20, 2024 | — |
| 10-Q | Quarterly report | Aug 5, 2024 | Jun 30, 2024 |
| DEFA14A | Additional proxy material | Jul 26, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 23, 2024 | Jul 22, 2024 |
| 8-K |
Current report
Other events
|
Jul 22, 2024 | Jul 19, 2024 |
| ARS | Annual report to shareholders | Jul 1, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Jul 1, 2024 | Jul 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 28, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 26, 2024 | Jun 25, 2024 |
| PRE 14A | Preliminary proxy statement | Jun 21, 2024 | Jun 21, 2024 |
| 8-K |
Current report
Listing notice
|
Jun 21, 2024 | Jun 18, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 6, 2024 | May 31, 2024 |
| 8-K/A |
Amended current report
Results of operations, Other events
|
May 24, 2024 | May 14, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 21, 2024 | May 17, 2024 |
| 424B5 | Prospectus supplement | May 17, 2024 | — |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 14, 2024 |
| 424B5 | Prospectus supplement | May 15, 2024 | — |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 424B5 | Prospectus supplement | May 9, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 9, 2024 | May 7, 2024 |
| RW | Filing | May 8, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 6, 2024 | May 6, 2024 |
| 424B5 | Prospectus supplement | May 6, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 3, 2024 | May 2, 2024 |
| 424B5 | Prospectus supplement | May 2, 2024 | — |
| 424B5 | Prospectus supplement | May 2, 2024 | — |
| 424B5 | Prospectus supplement | May 2, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 30, 2024 | Apr 29, 2024 |
| 10-K/A | Amended annual report | Apr 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 18, 2024 | Apr 17, 2024 |
| S-1/A | Amended registration statement | Apr 17, 2024 | — |
| 424B5 | Prospectus supplement | Apr 15, 2024 | — |
| 424B5 | Prospectus supplement | Apr 12, 2024 | — |
| 424B5 | Prospectus supplement | Apr 11, 2024 | — |
| 424B5 | Prospectus supplement | Apr 9, 2024 | — |
| S-1/A | Amended registration statement | Apr 8, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 5, 2024 | Apr 4, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Apr 4, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 1, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 26, 2024 | Mar 25, 2024 |
| S-8 | Employee stock plan registration | Mar 25, 2024 | — |
| 8-K |
Current report
Material agreement
|
Mar 20, 2024 | Mar 19, 2024 |
| 424B5 | Prospectus supplement | Mar 20, 2024 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
|
Mar 15, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 8, 2024 | Mar 8, 2024 |
| 10-K | Annual report | Mar 8, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Mar 8, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 1, 2024 | Feb 27, 2024 |
| UPLOAD | Letter from the SEC | Feb 27, 2024 | — |
| PRER14A | Revised preliminary proxy statement | Feb 23, 2024 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
|
Feb 14, 2024 | Feb 13, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2024 | — |
| D | Filing | Feb 2, 2024 | — |
| 8-K |
Current report
Agreement ended, Officer or director change
|
Feb 1, 2024 | Jan 26, 2024 |
| PRE 14A | Preliminary proxy statement | Jan 26, 2024 | Jan 26, 2024 |
| 8-K |
Current report
Material agreement
|
Jan 25, 2024 | Jan 25, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
|
Jan 19, 2024 | Jan 18, 2024 |
| S-1/A | Amended registration statement | Dec 15, 2023 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Dec 11, 2023 | Dec 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 6, 2023 | Dec 5, 2023 |
| S-1/A | Amended registration statement | Dec 6, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 5, 2023 | Dec 5, 2023 |
| S-1/A | Amended registration statement | Dec 5, 2023 | — |
| EFFECT | Filing | Nov 29, 2023 | — |
| CORRESP | Letter to the SEC | Nov 27, 2023 | — |
| 8-K |
Current report
Listing notice
|
Nov 17, 2023 | Nov 16, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 13, 2023 | Nov 13, 2023 |
| UPLOAD | Letter from the SEC | Nov 8, 2023 | — |
| S-3 | Shelf registration | Nov 2, 2023 | — |
| S-1 | Registration statement | Oct 30, 2023 | — |
| 8-K |
Current report
Listing notice
|
Oct 30, 2023 | Oct 27, 2023 |
| 424B3 | Prospectus | Oct 23, 2023 | — |
| EFFECT | Filing | Oct 19, 2023 | — |
| CORRESP | Letter to the SEC | Oct 17, 2023 | — |
| S-3/A | Amendment no. 1 to form s-3 | Oct 17, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 13, 2023 | — |
| S-3 | Shelf registration | Oct 10, 2023 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Sep 27, 2023 | Sep 22, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ALLR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1860657
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.